4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-041583
Chief Executive Officer sold 5,275 shares at $3.05 ($16,063)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-05 | Sale : show line 1 in the form 10b5-1 | −5,275 | $3.05 | $16,063 | 915,641 | D |
| Open-market sales · 5,275 sh · avg $3.05 · $16,063 | ||||||
Loading xslF345X04/doc4.xml…